Cooper Companies (The)

COO · NASDAQ · Health Care

$62.02▲ +2.78%

+$1.68 today

Mkt cap $12.10B
P/E 30.9
Day $61.09 – $62.97

Confidence

High conviction

menu_book

The read

Cooper Companies Q2 2026 Earnings Reported; EPS Actuals Pending, Stock Up 2.78%

Cooper Companies reported Q2 2026 earnings with EPS actuals not yet available; shares rose 2.78% on June 4, 2026. Analysts maintain a buy consensus with a $87.42 average target price amid mixed growth signals and solid valuation metrics.

Confidence note: Analysis is limited by unavailable EPS actuals but supported by price reaction, analyst consensus, and institutional ownership data.

fact_check

What happened

receipt_long

Earnings print

EPS actuals for Q2 2026 are not yet available; estimated EPS was $1.10.

signpost

Guidance

No updated guidance disclosed in the available data; analyst consensus remains buy with target price $87.42.

candlestick_chart

Price reaction

Shares increased 2.78% to $62.02 on the day of earnings release, indicating positive market sentiment despite missing EPS data.

newspaper

Street narrative

Despite the absence of reported EPS, the stock's positive price reaction and strong institutional ownership suggest investor confidence. Growth metrics are mixed, with below-sector revenue and EPS growth but solid forward EPS estimates and valuation.

lightbulb

So what

swap_horiz

What changed

EPS actuals remain unreported; stock price rose 2.78% post-earnings with no new guidance.

sell

What the market is pricing

Market is pricing cautious optimism, reflected in a 2.78% price gain amid incomplete earnings data.

insights

Fundamental takeaway

Maintain current thesis; monitor EPS actuals and next-quarter guidance for clarity on growth trajectory.

alt_route

Next 30–90 days

trending_upBull

48%

EPS actuals exceed estimates and next-quarter guidance improves, validating growth potential and supporting multiple expansion.

boltReported EPS above $1.10
boltPositive next-quarter revenue and EPS guidance

balanceBase

36%

EPS reported near estimates with stable guidance; valuation remains supported by strong institutional ownership and moderate growth.

boltEPS within ±5% of $1.10 estimate
boltStable or flat guidance

trending_downBear

16%

EPS misses estimates and guidance weakens, pressuring shares and raising valuation concerns amid below-sector growth.

boltEPS below $1.05
boltGuidance lowered for next quarter

checklist

What to do

account_balance_wallet

If you hold it

Hold shares unless EPS misses estimates by more than 5% or guidance is lowered next quarter.

visibility

If you're watching

Consider entry if EPS beats estimates and guidance improves; avoid if EPS is unreported or guidance is negative.

radar

Keep on your radar

EPS actual release date and value
Next-quarter revenue and EPS guidance by August 2026
Institutional ownership trends quarterly
Stock price relative to 50-day and 200-day moving averages